CLASS II ONGOING Device recall · Reported 11 Mar 2026 · FDA Enforcement Report

Atellica CH Urine Albumin (UAlb) recalled

Siemens Healthcare Diagnostics is recalling Atellica CH Urine Albumin (UAlb), distributed nationwide in the US. The recall was initiated on 20 Jan 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesMaterial Number: 11537225. UDI-DI: 00630414611099. Lot Numbers: All lot numbers.
Quantity recalled4,885 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1484-2026
FDA event ID
98370
Recalling firm
Siemens Healthcare Diagnostics, Tarrytown, NY
Classification
Class II
Status
Ongoing
Recall initiated
20 Jan 2026
FDA classified
2 Mar 2026
Reported
11 Mar 2026
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

20 Jan 2026Recall initiated by company
2 Mar 2026Classified by FDA+41 days
11 Mar 2026Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Falsely depressed UAlb patient results may occur. Affected samples with any urine albumin concentration above the UAlb measuring interval >40.0 mg/dL may report values between 6.2 mg/dL and 40.0 mg/dL.

Product as listed by the FDA

Atellica CH Urine Albumin (UAlb). Material Number: 11537225

Where it was distributed

Worldwide distribution - US Nationwide and the countries of Australia, Austria, Belgium, Brazil, Canada, Chile, Curacao,¿St¿Eus, Czech¿Republic, Denmark, Finland, France, Germany, Greece, Hong Kong, Ireland, Israel, Italy, Korea, Latvia, Malaysia, Netherlands, New Zealand, Norway, Portugal, Romania, Singapore, Slovakia, South Africa, Spain, Sweden, Switzerland, United¿Kingdom.

Nationwide

Questions about this recall

Why was it recalled?

Falsely depressed UAlb patient results may occur. Affected samples with any urine albumin concentration above the UAlb measuring interval >40.0 mg/dL may report values between 6.2 mg/dL and 40.0 mg/dL.

Which lots are affected?

Material Number: 11537225. UDI-DI: 00630414611099. Lot Numbers: All lot numbers.

Where was it sold?

Worldwide distribution - US Nationwide and the countries of Australia, Austria, Belgium, Brazil, Canada, Chile, Curacao,¿St¿Eus, Czech¿Republic, Denmark, Finland, France, Germany, Greece, Hong Kong, Ireland, Israel, Italy, Korea, Latvia, Malaysia, Netherlands, New Zealand, Norway, Portugal, Romania, Singapore, Slovakia, South Africa, Spain, Sweden, Switzerland, United¿Kingdom.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Siemens Healthcare Diagnostics

All 694

Other Other Medical Devices recalls

All 13,778